Loading chat...

RI S0486

Bill

Status

Introduced

2/26/2025

Primary Sponsor

Pamela Lauria

Click for details

Origin

Senate

2025 Regular Session

AI Summary

Legislative Description

Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.

State Affairs And Government

Last Action

Committee recommended measure be held for further study

3/20/2025

Committee Referrals

Health and Human Services2/26/2025

Full Bill Text

No bill text available